Drawing for ALBUMOD

USPTO serial 79325247

ALBUMOD

Reviewed by CopyMark Law Group

Reg. 7021137Status 700Registered
Filing date
Status date
Registration date
Apr 11, 2023
Examiner
BAL, KAMAL SINGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALBUMOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica S. Sachs

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098

Goods and services

ClassDescriptionStatusFirst use
001Chemical substance preparations, chemical materials preparations and chemical preparations all for scientific purposes, and chemical elements, namely, chemical elements used in pharmaceuticals for scientific purposes; chemical substances and materials used to enhance the efficacy of biopharmaceuticals for industrial, scientific and laboratory purposes; biochemical substances preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Biochemical reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting and verification use, other than for medical or veterinary purposes; reagents for research use in the development of antibodies, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; antibodies and antibodies-based chemical reagents for non-medical and non-veterinary useACTIVE—
005Medical and veterinary preparations and articles, namely, pharmaceutical preparations for half-life extension and enhancement of efficacy of protein therapeutics; pharmaceutical preparations and substances, namely, a pharmaceutical agent consisting of compounds comprised of albumin-binding domains and albumin that facilitate delivery of a wide range of pharmaceuticals; biochemical preparations for medical use for the treatment of systemic and local diseases; biochemical pharmaceutical preparations for medical use for half-life extension and enhancement of efficacy of protein therapeutics; antibodies and antibodies-based pharmaceutical preparations for medical purposes for half-life extension and enhancement of efficacy of protein therapeutics; diagnostic preparations and materials; reagents for medical use; biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; sanitary preparations for medical purposesACTIVE—
010Medical and veterinary apparatus and instruments, namely, medical apparatus and instruments for use in surgery; Diagnostic, examination, and monitoring equipment for medical use, namely, medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical and veterinary apparatus and instruments, namely, Hematology analyzers for medical diagnostic uses; Medical and veterinary apparatus and instruments, namely, Medical diagnostic instruments for the analysis of body fluids; Medical and veterinary apparatus and instruments, namely, X-ray diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for detecting cancer or and inflammation; Medical and veterinary apparatus and instruments, namely, Ultrasonic medical diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for testing DNA and RNA samples; Separation instruments for medical use, namely, blood component separation apparatus for medical purposes; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Gas chromatographic instruments for medical use; Electromagnetic diagnostic imaging apparatus for medical use; Medication fluid injectors for medical useACTIVE—
042Scientific and technological services and research, development and design in the fields of half-life extension, pharmacokinetics and pharmacodynamics; medical and pharmacological research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; medical, pharmaceutical and biotechnological laboratory research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; drug discovery services; pharmaceutical products development and evaluationACTIVE—
044medical services; providing medical information; physical examination services; medical diagnostic testing, monitoring and reporting services; optical medical imaging services for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 26, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 26, 2023FIMPFINAL DISPOSITION PROCESSED—
Jul 11, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jan 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 16, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 16, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 16, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 16, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 16, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 8, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 8, 2022RFRRREFUSAL PROCESSED BY MPU—
May 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2022DOCKASSIGNED TO EXAMINER—
Nov 16, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance